ClinicalTrials.Veeva

Menu

Effect of Triticale, Mung Bean and Adzuki Bean Intervention on Patients With Type 2 Diabetes

Chinese Academy of Medical Sciences & Peking Union Medical College logo

Chinese Academy of Medical Sciences & Peking Union Medical College

Status

Completed

Conditions

Type2 Diabetes Mellitus

Treatments

Dietary Supplement: triticale and mung bean
Dietary Supplement: adzuki bean

Study type

Interventional

Funder types

Other

Identifiers

NCT02999867
PUMCH-ZS-1048

Details and patient eligibility

About

This study is designed to evaluate short term effect of triticale, mung bean and adzuki bean intervention for health improvement in patients with type 2 diabetes.

Full description

The study will evaluate the effect of triticale, mung bean and adzuki bean on metabolic and nutritional status of patients with type 2 diabetes after 30 days of intervention. Patients will be assigned to control or intervention group (A diet including triticale and mung bean; B diet including adzuki bean). Blood and urine samples will be collected at baseline and after 30 days of intervention.

Enrollment

180 patients

Sex

All

Ages

30 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Male and female patients between the ages of 30 and 65 years
  2. patients has been diagnosed as type 2 diabetes mellitus
  3. Patients who like to be followed up for 2 months.

Exclusion criteria

  1. Women in pregnancy or lactation.
  2. Individuals with a history of severe kidney disease, cardiovascular disease, stroke, cancer, or psychological disorders.

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

180 participants in 2 patient groups

M1 triticale and mung bean
Experimental group
Description:
M1: triticale and mung bean as a processed food is assigned to patients at a dose of 50-100 g/d for 30-day dietary intervention.
Treatment:
Dietary Supplement: triticale and mung bean
M2 adzuki bean
Experimental group
Description:
M2: adzuki bean as a processed food is assigned to patients at a dose of 50-100 g/d for 30-day dietary intervention.
Treatment:
Dietary Supplement: adzuki bean

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems